The Irish Times

European share prices rise as Brexit concerns ease

Latest polls reveal campaign for Britain to remain in the EU has a one-point lead

Wed Jun 22 2016 - 01:00

Results of the active treatment groups in key clinical study were not significantly better than those on placebo

Mon Jun 20 2016 - 18:04

Life sciences group, set up by a number of ex-Elan executives, surpasses IPO target

Fri Mar 20 2015 - 08:01

Britsh fund manager Neil Woodford also purchasing shares

Thu Mar 05 2015 - 08:12

Former Elan boss Kelly Martin and chairman Bob Ingram to sit on company’s board

Fri Feb 27 2015 - 08:53

Top candidates for a share sale include Swiss firms AC Immune and Molecular Partners

Thu Mar 13 2014 - 19:00

Dicerna Pharmaceuticals a focal point of concern as it has yet to enter clinical trials and refused to impose share sale block on major shareholders

Mon Feb 10 2014 - 00:15